Image - Discover the First IFIGENEIA Newsletter!

Discover the First IFIGENEIA Newsletter!

Blog * 17th February 2026

The IFIGENEIA project has launched the first edition of its newsletter—an engaging snapshot of how the consortium is laying the groundwork for a new era of medical radioisotope production in Europe. This debut issue opens with a warm welcome from the coordination team and a clear overview of the project’s mission: building interconnected LINAC Excellence Hubs in Greece, Slovenia, and Cyprus to strengthen nuclear medicine and radiopharmaceutical supply across the region.

Readers can explore a range of highlights from the project’s early months. The newsletter presents IFIGENEIA’s brand-new visual identity, developed to capture the spirit of scientific innovation and cross-border collaboration. It also announces the launch of the project website, now serving as the main gateway to project updates, resources, and partner information.

One of the central stories in this edition is the Europe-wide hospital survey, designed to collect essential insights into radiopharmaceutical use, clinical needs, and supply challenges—key data that will directly shape future LINAC-based production.

The newsletter also takes readers behind the scenes of the kick-off meeting in Thessaloniki, showcases past and upcoming events, and includes a short “Did You Know?” feature about the project’s Excellence Hubs.

The first issue is now available for download—we invite you to dive in and explore the full newsletter.

More Blog Posts

IFIGENEIA fosters health innovation synergies

The participation of the IFIGENEIA team in the Open Ecosystem Event “Central Macedonia as a Digital Health Experimen...

Medical Radioisotopes Innovation in Central Macedonia

Advancing innovation in nuclear medicine, strengthening research capacity, and fostering collaboration across the he...

LabLogic drives Cypriot diagnostic imaging with complete QC solution

The Bank of Cyprus Oncology Center has chosen LabLogic to equip its cyclotron managed by BIOKOSMOS LabLogic has s...